Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Panvel Municipal Corporation Suspends Work At 34 Construction Projects For Pollution Norm Violations
Navi Mumbai MHADA Housing Scam: 66 Cheated Of ₹3.67 Crore, Rabale Police Arrest 1 Accused
Mumbai News: NCLT Approves Capri Global Resolution Plan For SevenHills Hospital, Clears Path For Revival
Bad News For Sanju Samson Fans? Ishan Kishan Takes Over Wicket-Keeping After Maiden Ton Ahead Of ICC T20 WC 2026
(With inputs from PTI)
